Aimovig of Amgen commence robust for migraine treatment The U.S. Food and Drug Administration (FDA) has given the approval to preventative migraine treatment, Aimovig of Amgen. Aimovig has a price ...
New areas of cancer treatment pop up every now and then without escaping our attention. And this time, it is—getting drugs directly into cancer tumors using Nanoparticles. If the buzz doing the rounds in the industry circles is to be believed, then a new cancer therapy, which will use Nanoparticles to deliver combi...
Find More
Merck & Company virology business is flickering, after announcing two of its new HIV medications that bagged approval from the Food and Drug Administration (FDA). The oral medications, Pifeltro and Delstrigo, are taken once-daily with or without food for adult HIV-1 patients, who have never received antiretrovir...
Find More
The Orphan Drug Act of 1983 was created to encourage pharmaceutical companies to develop drugs for so-called rare or ultra-rare diseases. The National Institutes of Health (NIH) defines rare diseases as afflicting as fewer than 200,000 individuals. Generally speaking, it has worked. Many companies are willing to inv...
Find More
National health authorities, U.K.'s NICE determines Gilead's cancer cell therapy exorbitant The National Institute for Health and Care Excellence (NICE) found Gilead's cancer cell therapy, Yescarta to be clinically efficacious for treating a type of lymphoma, but no ample evidence is present to estimate the benefit...
Find More
HOA Puts into Operation of Updated CyberKnife Version Cancer patients now have a solid reason to cheer, as US-based Hematology-Oncology Associates (HOA) lately came up with the new CyberKnife (CK) and replaced their original CyberKnife with an updated that is even more precise, fast and effective, and known as the ...
Find More
Can CRISPR really fix genetic mutation in human embryos? Team of scientists who created controversial blockbuster last year claim that they have fixed a disease-causing mutation in human embryos using gene editing technique CRISPR. Team has released fresh evidence supporting their work. Critics argued that the ev...
Find More
Teva’s migraine drug is expected to launch this year despite the delay in FDA approval Teva Pharmaceutical’s fremanezumab for treating migraine is expected to launch later this year. Celltrion disclosed that U.S. drug regulators issued a Form 483 for its plant in Incheon, South Korea on tuesdsy. Eight manufacturin...
Find More
‘Reprogrammed’ stem cells to be tested in people with Parkinson’s Doctors in Japan are poised to implant neural cells made from ‘reprogrammed’ stem cells into the brains of people with Parkinson’s disease. It is only the third clinical application of induced pluripotent stem (iPS) cells, which are developed by repro...
Find More
The FDA has approved AbbVie's Gonadotropin-Releasing Hormone (GnRH) antagonist Elagolix on Tuesday. FDA has given green light to the first oral treatment for endometriosis pain. The drug is branded as Orilissa, and is expected to be available in U.S. pharmacies in August. It will carry a list price of about $850 per...
Find More
Delivery of therapeutics to the human eye is among the most interesting endeavours a formulator can .....
Find More
Healthcare Performance Improvement provides proven methods for sustaining and building a culture of .....
Find More
Advances in continuous glucose monitoring (CGM) has led to a paradigm shift in the management of typ.....
Find More.png)
Today, the sedentary lifestyle adopted among people has led to cause a myriad of underlying diseases.....
Find More
Progressive Supranuclear Palsy (PSP) is a rare progressive disorder resulting from damage that occur.....
Find More
Though appear rare, rare diseases are far from being rare. With over 7,000 rare disease affecting mi.....
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
